Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
-
Second Sight Medical (EYES) Announces Researchers Present Latest Positive Results of Orion Visual Cortical Prosthesis Feasibility Study
-
Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study
-
Renovo and Seagate work together to develop next generation data management solutions for autonomous vehicles
-
Renovo and Seagate work together to develop next generation data management solutions for autonomous vehicles
-
Jet Linx Celebrates Formal Grand Opening of New Boston Private Terminal at Hanscom Field
-
Argus Starts Corteva Inc. (CTVA) at Hold
-
Reolink Works With Google Assistant, Spearheading a New Era of Connected and Smart Home
-
Private Jet Company New Flight Charters Sponsors Race Across America (RAAM) Cycling Team
-
Argus Starts Citizens Financial Group (CFG) at Hold
-
UPDATE: Argus Downgrades Regeneron Pharma (REGN) to Hold
-
Argus appoints Christopher Flook as head of European operations
-
Argus and IFDC bring transparency to Africa's fertilizer markets
-
PNM Resources (PNM) PT Raised to $55 at Argus
-
Argus Reiterates Hold Rating on Capri Holdings (CPRI)
-
Jet Linx Voluntarily Grounds Fleet For Annual Safety Summit
-
Humana (HUM) PT Lowered to $300 at Argus
-
Finistere, OurCrowd, Tnuva, and Tempo Awarded Government Tender to Operate Israel’s FoodTech Incubator in the North
-
Colgate-Palmolive Company (CL) PT Raised to $82 at Argus
-
Ligand Pharma (LGND) PT Lowered to $140 at Argus, Weakness Offers Buying Opportunity
-
Renault and Nissan launch innovation lab in Tel Aviv
-
How much does lithium cost? The industry can't seem to agree
-
UPDATE: Argus Downgrades Skyworks Solutions (SWKS) to Hold
-
As Permian oil production turns lighter, price outlook darkens
-
Exclusive: Pentagon eyes rare earth supplies in Africa in push away from China
-
OurCrowd & NOAH Advisors Partner to Jointly Promote Startup Investments in Europe
-
Argus Starts Equinix (EQIX) at Buy
-
Argus launches IMO 2020-compliant assessments for Zhoushan, China
-
UPDATE: Argus Downgrades Abercrombie & Fitch (ANF) to Hold
-
Argus Starts Huntington Bancshares (HBAN) at Hold
-
Argus Downgrades Lions Gate (LGF) to Hold
-
Argus Upgrades Anheuser-Busch InBev (BUD) to Buy
-
Alec Ellison Appointed Chairman of OurCrowd United States
-
Advance Auto Parts (AAP) PT Raised to $191 at Argus
-
Finistere Ventures, OurCrowd, Tnuva, and Tempo Beverages Announce Partnership to Invest $100 Million in Israeli FoodTech and AgTech Innovation
-
Argus Downgrades Expedia (EXPE) to Hold
-
Argus Upgrades AES Corp. (AES) to Buy
-
Argus Downgrades Bristol-Myers Squibb Co. (BMY) to Hold
-
Argus Downgrades Clorox (CLX) to Hold
-
Argus Downgrades Wolverine World Wide (WWW) to Hold
-
MultiVu - Advanced Photography Technologies (MV-APT, Ltd.) Raises $7M to Revolutionize Next Gen 3D Sensor Technologies
-
UPDATE: Argus Downgrades Livent Corp. (LTHM) to Hold
-
Argus Downgrades Occidental Petroleum (OXY) to Hold
-
Second Sight Reports First Quarter 2019 Financial Results
-
Second Sight Medical (EYES) to Accelerate Development of Orion Visual Cortical Prosthesis System
-
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
-
Argus Downgrades Buckeye (BPL) to Sell
-
Jet Linx Furthers National Expansion By Acquiring Elliott Aviation's Private Jet Management Business
-
UPDATE: Argus Upgrades Tyson (TSN) to Buy
-
Lucidea’s Essentia Program: ILS, KM and Collections Management for Small Organizations

